Skip to content

Study on the regulatory mechanism of menstrual adjustment and pregnancy promotion needle method on brain function network in DOR patients based on rs-fMRI technology

Study on the regulatory mechanism of menstrual adjustment and pregnancy promotion needle method on brain function network in DOR patients based on rs-fMRI technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070142
Enrollment
Unknown
Registered
2023-04-03
Start date
2023-04-06
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased ovarian reserve

Interventions

Sponsors

Shandong Provincial Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: DOR Group: ?AMH<1.1ng/ml ?In the early follicular stage, vaginal ultrasound showed that the number of bilateral ovarian sinus follicles (the number of follicles with a diameter of 2-9mm) AFC < 5-7 ?10IU/L<bFSH<20IU/L The interval between the two tests is greater than 4 weeks, and any of the above two are met, is diagnosed as DOR. (4) 18 years old= age = 40 years old; (5) right-handed; (6) No acupuncture treatment in the past 1 month; Healthy People Group: (1) 18-40 years old; (2) normal ovarian function; (3) Normal immune function and no immune diseases; (4) The patient is informed and signs the informed consent form.

Exclusion criteria

Exclusion criteria: DOR Group: Patients with congenital developmental abnormalities of reproductive organs, bilateral oophorectomy; Endocrine diseases such as polycystic ovary syndrome, hyperprolactinemia, hyperandrogenemia, hypothyroidism, and chronic adrenal insufficiency; Patients with severe cardiovascular and cerebrovascular, liver, kidney, malignant tumors, hematopoietic system and psychiatric diseases; Those with contraindications to magnetic resonance scanning, such as non-removable metal substances installed in the body, claustrophobia syndrome, etc. Healthy People Group: Patients with severe cardiovascular and cerebrovascular,liver,kidney,malignant tumors, hematopoietic system and psychiatric diseases.

Design outcomes

Primary

MeasureTime frame
Kupperman scale;Self-Rating Anxiety Scale;Self-Rating Depression Scale;

Secondary

MeasureTime frame
follicle-stimulating hormone;luteinizing hormone;estradiol;Anti-Mullerian bormone;Antral Follicle Counting;rs-fMRI;

Countries

China

Contacts

Public ContactBai Tianyu

Shandong Provincial Third Hospital

740724158@qq.com+86 15168879181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026